{"entity":{"type":"insider","cik":"0001720974","url":"/insider/0001720974","json_url":"/insider/0001720974.json","name":"Mahadevia Ankit","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":14,"first":"2018-07-06","last":"2025-09-03","span_basis":"filed_date"},"name_variants":[{"name":"Mahadevia Ankit","source":"filing","n_filings":14,"first_seen":"2018-07-06","last_seen":"2025-09-03"}],"transactions":[{"id":4983891,"accession":"0000950170-25-112661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-112661","line_url":"/filing/0000950170-25-112661#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6572.0,"shares_display":"6,572","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":12946.84,"total_display":"12,946.84","shares_owned_after":703294.0,"shares_owned_after_display":"703,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-09-03","scope":"insider"},{"id":4193873,"accession":"0000950170-25-014849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-014849","line_url":"/filing/0000950170-25-014849#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55260.0,"shares_display":"55,260","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":43102.8,"total_display":"43,102.80","shares_owned_after":689866.0,"shares_owned_after_display":"689,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider"},{"id":4193868,"accession":"0000950170-25-014849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-014849","line_url":"/filing/0000950170-25-014849#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13959.0,"shares_display":"13,959","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":10888.02,"total_display":"10,888.02","shares_owned_after":745126.0,"shares_owned_after_display":"745,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider"},{"id":3075361,"accession":"0000950170-24-102000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-102000","line_url":"/filing/0000950170-24-102000#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5912.0,"shares_display":"5,912","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":7981.2,"total_display":"7,981.20","shares_owned_after":759085.0,"shares_owned_after_display":"759,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":3212915,"accession":"0000950170-24-011496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-011496","line_url":"/filing/0000950170-24-011496#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63795.0,"shares_display":"63,795","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":87399.15,"total_display":"87,399.15","shares_owned_after":744997.0,"shares_owned_after_display":"744,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":8599601,"accession":"0000950170-23-045442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-045442","line_url":"/filing/0000950170-23-045442#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9040.0,"shares_display":"9,040","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":11390.4,"total_display":"11,390.40","shares_owned_after":788792.0,"shares_owned_after_display":"788,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":7854879,"accession":"0000899243-23-004039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-004039","line_url":"/filing/0000899243-23-004039#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12286.0,"shares_display":"12,286","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":22237.66,"total_display":"22,237.66","shares_owned_after":797832.0,"shares_owned_after_display":"797,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-06","scope":"insider"},{"id":5365262,"accession":"0000899243-21-050049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-050049","line_url":"/filing/0000899243-21-050049#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.5833,"price_display":"14.58","price_state":"stated","total_value":116666.4,"total_display":"116,666.40","shares_owned_after":144036.0,"shares_owned_after_display":"144,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-29","scope":"insider"},{"id":2953853,"accession":"0000899243-20-030490","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030490","line_url":"/filing/0000899243-20-030490#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7370.0,"shares_display":"7,370","price_per_share":14.4281,"price_display":"14.43","price_state":"stated","total_value":106335.097,"total_display":"106,335.10","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-05","scope":"insider"},{"id":2953844,"accession":"0000899243-20-030490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030490","line_url":"/filing/0000899243-20-030490#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2137.0,"shares_display":"2,137","price_per_share":14.2675,"price_display":"14.27","price_state":"stated","total_value":30489.6475,"total_display":"30,489.65","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2329523,"accession":"0000899243-20-029328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-029328","line_url":"/filing/0000899243-20-029328#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":285.0,"total_display":"285.00","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-23","filed_date":"2020-10-27","scope":"insider"},{"id":2133481,"accession":"0000899243-20-028430","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-028430","line_url":"/filing/0000899243-20-028430#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105.0,"shares_display":"105","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":1496.25,"total_display":"1,496.25","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-15","scope":"insider"},{"id":2133475,"accession":"0000899243-20-028430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-028430","line_url":"/filing/0000899243-20-028430#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14367.0,"shares_display":"14,367","price_per_share":14.2836,"price_display":"14.28","price_state":"stated","total_value":205212.4812,"total_display":"205,212.48","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-15","scope":"insider"},{"id":3319643,"accession":"0000899243-20-024865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-024865","line_url":"/filing/0000899243-20-024865#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":774.0,"shares_display":"774","price_per_share":14.2503,"price_display":"14.25","price_state":"stated","total_value":11029.7322,"total_display":"11,029.73","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2773182,"accession":"0000899243-20-018847","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-018847","line_url":"/filing/0000899243-20-018847#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2293.0,"shares_display":"2,293","price_per_share":14.3073,"price_display":"14.31","price_state":"stated","total_value":32806.6389,"total_display":"32,806.64","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-09","scope":"insider"},{"id":2773173,"accession":"0000899243-20-018847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-018847","line_url":"/filing/0000899243-20-018847#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":754.0,"shares_display":"754","price_per_share":14.2506,"price_display":"14.25","price_state":"stated","total_value":10744.9524,"total_display":"10,744.95","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2730921,"accession":"0001209191-20-039352","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-039352","line_url":"/filing/0001209191-20-039352#line-8","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2642.0,"shares_display":"2,642","price_per_share":14.2507,"price_display":"14.25","price_state":"stated","total_value":37650.3494,"total_display":"37,650.35","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-29","scope":"insider"},{"id":2730914,"accession":"0001209191-20-039352","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-039352","line_url":"/filing/0001209191-20-039352#line-6","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3880.0,"shares_display":"3,880","price_per_share":14.2834,"price_display":"14.28","price_state":"stated","total_value":55419.592,"total_display":"55,419.59","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-24","filed_date":"2020-06-29","scope":"insider"},{"id":2730905,"accession":"0001209191-20-039352","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-039352","line_url":"/filing/0001209191-20-039352#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8045.0,"shares_display":"8,045","price_per_share":14.3274,"price_display":"14.33","price_state":"stated","total_value":115263.933,"total_display":"115,263.93","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-29","scope":"insider"},{"id":2730897,"accession":"0001209191-20-039352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-039352","line_url":"/filing/0001209191-20-039352#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2613.0,"shares_display":"2,613","price_per_share":14.2996,"price_display":"14.30","price_state":"stated","total_value":37364.8548,"total_display":"37,364.85","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-29","scope":"insider"},{"id":6178210,"accession":"0000899243-18-019566","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-10","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","shares_owned_after":66917.0,"shares_owned_after_display":"66,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178204,"accession":"0000899243-18-019566","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-9","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":17.58,"price_display":"17.58","price_state":"stated","total_value":7032.0,"total_display":"7,032.00","shares_owned_after":66417.0,"shares_owned_after_display":"66,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178198,"accession":"0000899243-18-019566","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-8","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.92,"price_display":"17.92","price_state":"stated","total_value":3584.0,"total_display":"3,584.00","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178194,"accession":"0000899243-18-019566","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-7","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.9,"price_display":"17.90","price_state":"stated","total_value":3580.0,"total_display":"3,580.00","shares_owned_after":66017.0,"shares_owned_after_display":"66,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178186,"accession":"0000899243-18-019566","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-6","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.705,"price_display":"17.70","price_state":"stated","total_value":1770.5,"total_display":"1,770.50","shares_owned_after":66217.0,"shares_owned_after_display":"66,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178179,"accession":"0000899243-18-019566","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-5","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.62,"price_display":"17.62","price_state":"stated","total_value":1762.0,"total_display":"1,762.00","shares_owned_after":66317.0,"shares_owned_after_display":"66,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178175,"accession":"0000899243-18-019566","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-4","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.545,"price_display":"17.54","price_state":"stated","total_value":1754.5,"total_display":"1,754.50","shares_owned_after":66817.0,"shares_owned_after_display":"66,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"},{"id":6178164,"accession":"0000899243-18-019566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-019566","line_url":"/filing/0000899243-18-019566#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001720974","owner_name":"Mahadevia Ankit","owner_url":"/insider/0001720974","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3076.0,"shares_display":"3,076","price_per_share":17.6215,"price_display":"17.62","price_state":"stated","total_value":54203.734,"total_display":"54,203.73","shares_owned_after":65817.0,"shares_owned_after_display":"65,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701108","name":"Spero Therapeutics, Inc.","url":"/issuer/0001701108","role":"Director, Officer (CEO and President)","n_filings":14,"first_seen":"2018-07-06","last_seen":"2025-09-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001720974","retrieved_at":"2026-08-21T14:54:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}